Striatin-3γ inhibits estrogen receptor activity by recruiting a protein phosphatase

Journal of Molecular Endocrinology

Volumn 40, Issue 5-6, 2008, Pages 199-210

  Tan, Bailin ^a   Long, Xinghua ^a   Nakshatri, Harikrishna ^a   Nephew, Kenneth P ^a   Bigsby, Robert M ^a  

^a INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ESTRADIOL; ESTROGEN RECEPTOR ALPHA; OKADAIC ACID; PHOSPHOPROTEIN PHOSPHATASE 2A; REGULATOR PROTEIN; SMALL INTERFERING RNA; STRIATIN 3 GAMMA; ANTIESTROGEN; AUTOANTIGEN; CALMODULIN BINDING PROTEIN; ESTROGEN RECEPTOR; GS2NA PROTEIN, RAT; ISOPROTEIN; PHOSPHOPROTEIN PHOSPHATASE 2; STRN3 PROTEIN, HUMAN;

ANIMAL CELL; ARTICLE; CANCER CELL CULTURE; CONTROLLED STUDY; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION; RAT; TRANSCRIPTION REGULATION; AMINO ACID SEQUENCE; ANIMAL; CELL STRAIN COS1; CERCOPITHECUS; DRUG ANTAGONISM; FEMALE; GENETICS; HELA CELL; METABOLISM; MOLECULAR GENETICS; MOUSE; PHOSPHORYLATION; PHYSIOLOGY; TUMOR CELL LINE;

AMINO ACID SEQUENCE; ANIMALS; AUTOANTIGENS; CALMODULIN-BINDING PROTEINS; CELL LINE, TUMOR; CERCOPITHECUS AETHIOPS; COS CELLS; ESTROGEN ANTAGONISTS; ESTROGEN RECEPTOR ALPHA; FEMALE; HELA CELLS; HUMANS; MICE; MOLECULAR SEQUENCE DATA; PHOSPHORYLATION; PROTEIN ISOFORMS; PROTEIN PHOSPHATASE 2; RATS; RECEPTORS, ESTROGEN;

EID: 45549086138     PISSN: 09525041     EISSN: None     Source Type: Journal    
DOI: 10.1677/JME-07-0132     Document Type: Article

References (63)

1. Ali S, Metzger D, Bornert J & Chambon P 1993 Modulation of transcriptional activation by ligand-dependent phosphorylation of the human oestrogen receptor A/B region. EMBO Journal 12 1153-1160.
2. Bartoli M, Monneron A & Ladant D 1998 Interaction of calmodulin with striatin, a WD-repeat protein present in neuronal dendritic spines. Journal of Biological Chemistry 273 22248-22253.
3. Beck C, Weigel N & Edwards D 1992 Effects of hormone and cellular modulators of protein phosphorylation on transcriptional activity, DNA binding, and phosphorylation of human progesterone receptors. Molecular Endocrinology 6 607-620.
4. Bhattacharjee R, Banks G, Trotter K, Lee H & Archer T 2001 Histone H1 phosphorylation by Cdk2 selectively modulates mouse mammary tumor virus transcription through chromatin remodeling. Molecular and Cell Biology 21 5417-5425.
5. Bigsby R & Li A 1994 Differentially regulated immediate early genes in the rat uterus. Endocrinology 134 1820-1826.
6. Borras M, Hardy L, Lempereur F, el Khissiin A, Legros N, Gol-Winkler R & Leclercq G 1994 Estradiol-induced down-regulation of estrogen receptor. Effect of various modulators of protein synthesis and expression. Journal of Steroid Biochemistry and Molecular Biology 48 325-336.
7. Brown A, Jeltsch J, Roberts M & Chambon P 1984 Activation of pS2 gene transcription is a primary response to estrogen in the human breast cancer cell line MCF-7. PNAS 81 6344-6348.
8. Campbell R, Bhat-Nakshatri P, Patel N, Constantinidou D, Ali S & Nakshatri H 2001 Phosphatidylinositol 3-kinase/AKT-mediated activation of estrogen receptor alpha: a new model for anti-estrogen resistance. Journal of Biological Chemistry 276 9817-9824.
9. Castets F, Bartoli M, Barnier J, Baillat G, Salin P, Moqrich A, Bourgeois J, Denizot F, Rougon G, Calothy G et al. 1996 A novel calmodulin-binding protein, belonging to the WD-repeat family, is localized in dendrites of a subset of CNS neurons. Journal of Cell Biology 134 1051-1062.
10. Castets F, Rakitina T, Gaillard S, Moqrich A, Mattei M & Monneron A 2000 Zinedin, SG2NA, and striatin are calmodulin-binding, WD repeat proteins principally expressed in the brain. Journal of Biological Chemistry 275 19970-19977.
11. Cavailles V, Garcia M & Rochefort H 1989 Regulation of cathepsin-D and pS2 gene expression by growth factors in MCF7 human breast cancer cells. Molecular Endocrinology 3 552-558.
12. Chen D, Riedl T, Washbrook E, Pace P, Coombes R, Egly J & Ali S 2000 Activation of estrogen receptor alpha by S118 phosphorylation involves a ligand-dependent interaction with TFIIH and participation of CDK7. Molecular Cell 6 127-137.
13. Chen D, Washbrook E, Sarwar N, Bates G, Pace P, Thirunuvakkarasu V, Taylor J, Epstein R, Fuller-Pace F, Egly J et al. 2002 Phosphorylation of human estrogen receptor alpha at serine 118 by two distinct signal transduction pathways revealed by phosphorylation-specific antisera. Oncogene 21 4921-4931.
14. Clark D, Poteet-Smith C, Smith J & Lannigan D 2001 Rsk2 allosterically activates estrogen receptor alpha by docking to the hormone-binding domain. EMBO Journal 20 3484-3494.
15. Csortos C, Zolnierowicz S, Bako E, Durbin S & DePaoli-Roach A 1996 High complexity in the expression of the B′ subunit of protein phosphatase 2A0. Evidence for the existence of at least seven novel isoforms. Journal of Biological Chemistry 271 2578-2588.
16. Dean D, Urban G, Aragon I, Swingle M, Miller B, Rusconi S, Bueno M, Dean N & Honkanen R 2001 Serine/threonine protein phosphatase 5 (PP5) participates in the regulation of glucocorticoid receptor nucleocytoplasmic shuttling. BMC Cell Biology 2 6.
17. DeFranco D, Qi M, Borror K, Garabedian MJ & Brautigan D 1991 Protein phosphatase types 1 and/or 2A regulate nucleocytoplasmic shuttling of glucocorticoid receptors. Molecular Endocrinolgy 5 1215-1228.
18. Depaoli-Roach A, Park I, Cerovsky V, Csortos C, Durbin S, Kuntz M, Sitikov A, Tang P, Verin A & Zolnierowicz S 1994 Serine/threonine protein phosphatases in the control of cell function. Advances in Enzyme Regulation 34 199-224.
19. Edwards D 2005 Regulation of signal transduction pathways by estrogen and progesterone. Annual Review of Physiology 67 335-376.
20. Fan M, Long X, Bailey J, Reed C, Osborne E, Gize E, Kirk E, Bigsby R & Nephew K 2002 The activating enzyme of NEDD8 inhibits steroid receptor function. Molecular Endocrinology 16 315-330.
21. Fan M, Bigsby R & Nephew K 2003 The NEDD8 pathway is required for proteasome-mediated degradation of human estrogen receptor (ER)-alpha and essential for the antiproliferative activity of ICI 182,780 in ERα-positive breast cancer cells. Molecular Endocrinology 17 356-365.
22. Favre B, Turowski P & Hemmings B 1997 Differential inhibition and posttranslational modification of protein phosphatase 1 and 2A in MCF7 cells treated with calyculin-A, okadaic acid, and tautomycin. Journal of Biological Chemistry 272 13856-13863.
23. Font de Mora J & Brown M 2000 AIB1 is a conduit for kinase-mediated growth factor signaling to the estrogen receptor. Molecular and Cell Biology 20 5041-5047.
24. Frasor J, Danes J, Komm B, Chang K, Lyttle C & Katzenellenbogen B 2003 Profiling of estrogen up- and down-regulated gene expression in human breast cancer cells: insights into gene networks and pathways underlying estrogenic control of proliferation and cell phenotype. Endocrinology 144 4562-4574.
25. Frodin M & Gammeltoft S 1999 Role and regulation of 90 kDa ribosomal S6 kinase (RSK) in signal transduction. Molecular and Cellular Endocrinology 151 65-77.
26. Galigniana M, Housley P, DeFranco D & Pratt W 1999 Inhibition of glucocorticoid receptor nucleocytoplasmic shuttling by okadaic acid requires intact cytoskeleton. Journal of Biological Chemistry 274 16222-16227.
27. Gopalakrishna R, Gundimeda U, Fontana J & Clarke R 1999 Differential distribution of protein phosphatase 2A in human breast carcinoma cell lines and its relation to estrogen receptor status. Cancer Letters 136 143-151.
28. Hermanson O, Jepsen K & Rosenfeld M 2002 N-CoR controls differentiation of neural stem cells into astrocytes. Nature 419 934-939.
29. Ikeda K, Ogawa S, Tsukui T, Horie-Inoue K, Ouchi Y, Kato S, Muramatsu M & Inoue S 2004 Protein phosphatase 5 is a negative regulator of estrogen receptor-mediated transcription. Molecular Endocrinology 18 1131-1143.
30. Ikonen T, Palvimo J, Kallio P, Reinikainen P & Janne O 1994 Stimulation of androgen-regulated transactivation by modulators of protein phosphorylation. Endocrinology 135 1359-1366.
31. Ismaili N & Garabedian M 2004 Modulation of glucocorticoid receptor function via phosphorylation. Annals of the New York Academy of Science 1024 86-101.
32. Janssens V & Goris J 2001 Protein phosphatase 2A: a highly regulated family of serine/threonine phosphatases implicated in cell growth and signalling. Biochemical Journal 353 417-439.
33. Kato S 2001 Estrogen receptor-mediated cross-talk with growth factor signaling pathways. Breast Cancer 8 3-9.
34. Keen J, Zhou Q, Park B, Pettit C, Mack K, Blair B, Brenner K & Davidson N 2005 Protein phosphatase 2A (PP2A) regulates estrogen receptor alpha (ER) expression through modulation of ER mRNA stability. Journal of Biological Chemistry 280 29519-29524.
35. Landberg G & Tan E 1994 Characterization of a DNA-binding nuclear autoantigen mainly associated with S phase and G2 cells. Experimental Cell Research 212 255-261.
36. Levin E 2003 Bidirectional signaling between the estrogen receptor and the epidermal growth factor receptor. Molecular Endocrinology 17 309-317.
37. Likhite VS, Stossi F, Kim K, Katzenellenbogen BS & Katzenellenbogen JA 2006 Kinase-specific phosphorylation of the estrogen receptor changes receptor interactions with ligand, deoxyribonucleic acid, and coregulators associated with alterations in estrogen and tamoxifen activity. Molecular Endocrinology 20 3120-3132.
38. Long X, Gize EA, Nephew K & Bigsby RM 2001 Evidence for estrogenic contamination of the MAPK inhibitor PD98059. Endocrinology 142 5390-5393.
39. Loose-Mitchell D, Chiappetta C & Stancel G 1988 Estrogen regulation of c-fos messenger ribonucleic acid. Molecular Endocrinology 2 946-951.
40. Lu Q, Surks H, Ebling H, Baur W, Brown D, Pallas D & Karas R 2003 Regulation of estrogen receptor alpha -mediated transcription by a direct interaction with protein phosphatase 2A. Journal of Biological Chemistry 278 4639-4645.
41. Lu Q, Pallas D, Surks H, Baur W, Mendelsohn M & Karas R 2004 Striatin assembles a membrane signaling complex necessary for rapid, nongenomic activation of endothelial NO synthase by estrogen receptor alpha. PNAS 101 17126-17131.
42. Martin M, Franke T, Stoica G, Chambon P, Katzenellenbogen B, Stoica B, McLemore M, Olivo S & Stoica A 2000 A role for Akt in mediating the estrogenic functions of epidermal growth factor and insulin-like growth factor I. Endocrinology 141 4503-4511.
43. McKenna NJ & O'Malley BW 2002 Combinatorial control of gene expression by nuclear receptors and coregulators. Cell 108 465-474.
44. McKenzie G, Stevenson P, Ward G, Papadia S, Bading H, Chawla S, Privalsky M & Hardingham G 2005 Nuclear Ca2+ and CaM kinase IV specify hormonal- and Notch-responsiveness. Journal of Neurochemistry 93 171-185.
45. Metivier R, Penot G, Hubner M, Reid G, Brand H, Kos M & Gannon F 2003 Estrogen receptor-alpha directs ordered, cyclical, and combinatorial recruitment of cofactors on a natural target promoter. Cell 115 751-763.
46. Migliaccio A, Castoria G, Di Domenico M, de Falco A, Bilancio A, Lombardi M, Bottero D, Varricchio L, Nanayakkara M, Rotondi A et al. 2002 Sex steroid hormones act as growth factors. Journal of Steroid Biochemistry and Molecular Biology 83 31-35.
47. Moreno C, Park S, Nelson K, Ashby D, Hubalek F, Lane W & Pallas D 2000 WD40 repeat proteins striatin and S/G(2) nuclear autoantigen are members of a novel family of calmodulin-binding proteins that associate with protein phosphatase 2A. Journal of Biological Chemistry 275 5257-5263.
48. Moreno C, Lane W & Pallas D 2001 A mammalian homolog of yeast MOB1 is both a member and a putative substrate of striatin family-protein phosphatase 2A complexes. Journal of Biological Chemistry 276 24253-24260.
49. Muro Y, Chan E, Landberg G & Tan E 1995 A cell-cycle nuclear autoantigen containing WD-40 motifs expressed mainly in S and G2 phase cells. Biochemical and Biophysical Research Communications 207 1029-1037.
50. Narayanan R, Edwards D & Weigel N 2005 Human progesterone receptor displays cell cycle-dependent changes in transcriptional activity. Molecular and Cell Biology 25 2885-2898.
51. Qiu M, Olsen A, Faivre E, Horwitz K & Lange C 2003 Mitogen-activated protein kinase regulates nuclear association of human progesterone receptors. Molecular Endocrinology 17 628-642.
52. Schonthal A 2001 Role of serine/threonine protein phosphatase 2A in cancer. Cancer Letters 170 1-13.
53. Shang Y, Hu X, DiRenzo J, Lazar M & Brown M 2000 Cofactor dynamics and sufficiency in estrogen receptor-regulated transcription. Cell 103 843-852.
54. Smith C 1998 Cross-talk between peptide growth factor and estrogen receptor signaling pathways. Biological Reproduction 58 627-632.
55. Smith C & O'Malley B 2004 Coregulator function: a key to understanding tissue specificity of selective receptor modulators. Endocrine Reviews 25 45-71.
56. Sola M, Langan T & Cohen P 1991 p34cdc2 phosphorylation sites in histone H1 are dephosphorylated by protein phosphatase 2A1. Biochimica et Biophysic Acta 1094 211-216.
57. Sontag E 2001 Protein phosphatase 2A: the Trojan Horse of cellular signaling. Cell Signalling 13 7-16.
58. Weisz A & Bresciani F 1988 Estrogen induces expression of c-fos and c-myc protooncogenes in rat uterus. Molecular Endocrinology 2 816-824.
59. White J, Fernandes I, Mader S & Yang X 2004 Corepressor recruitment by agonist-bound nuclear receptors. Vitamins and Hormone 68 123-143.
60. Wu R, Qin J, Yi P, Wong J, Tsai S, Tsai M & O'Malley B 2004 Selective phosphorylations of the SRC-3/AIB1 coactivator integrate genomic reponses to multiple cellular signaling pathways. Molecular Cell 15 937-949.
61. Yoshinari K, Kobayashi K, Moore R, Kawamoto T & Negishi M 2003 Identification of the nuclear receptor CAR:HSP90 complex in mouse liver and recruitment of protein phosphatase 2A in response to phenobarbital. FEBS Letters 548 17-20.
62. Zhu W, Chan E, Li J, Hemmerich P & Tan E 2001 Transcription activating property of autoantigen SG2NA and modulating effect of WD-40 repeats. Experimental Cell Research 269 312-321.
63. Zuo Z, Urban G, Scammell J, Dean N, McLean T, Aragon I & Honkanen R 1999 Ser/Thr protein phosphatase type 5 (PP5) is a negative regulator of glucocorticoid receptor-mediated growth arrest. Biochemistry 38 8849-8857.